Factor inhibiting HIF negatively regulates antiviral innate immunity via hydroxylation of IKKϵ

Cell Rep. 2024 Jan 23;43(1):113606. doi: 10.1016/j.celrep.2023.113606. Epub 2023 Dec 20.

Abstract

Activation of type I interferon (IFN-1) signaling is essential to protect host cells from viral infection. The full spectrum of IFN-I induction requires the activation of a number of cellular factors, including IκB kinase epsilon (IKKϵ). However, the regulation of IKKϵ activation in response to viral infection remains largely unknown. Here, we show that factor inhibiting hypoxia-inducible factor (HIF) (FIH), an asparaginyl hydroxylase, interacts with IKKϵ and catalyzes asparagine hydroxylation of IKKϵ at Asn-254, Asn-700, and Asn-701, resulting in the suppression of IKKϵ activation. FIH-mediated hydroxylation of IKKϵ prevents IKKϵ binding to TBK1 and TRAF3 and attenuates the cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex-catalyzed K63-linked polyubiquitination of IKKϵ at Lys-416. In addition, Fih-deficient mice and zebrafish are more resistant to viral infection. This work uncovers a previously unrecognized role of FIH in suppressing IKKϵ activation for IFN signaling and antiviral immune responses.

Keywords: CP: Immunology; FIH; IKKϵ; MAVS; TBK1; TRAF3; hydroxylation; hypoxia; innate immunity; mouse; zebrafish.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Hydroxylation
  • I-kappa B Kinase* / metabolism
  • Immunity, Innate
  • Mice
  • Repressor Proteins / metabolism
  • Virus Diseases*
  • Zebrafish / metabolism

Substances

  • I-kappa B Kinase
  • Repressor Proteins